NRSN — NeuroSense Therapeutics
No analyst calls on NRSN have been updated in the last 12 months — 1 analysts with 2 older calls are on record.
Who has covered NRSN?
See the full call history, price targets and the analysts' track records for NeuroSense Therapeutics — plus the full analyst rankings, firm analytics and screener.
No calls on NRSN were updated in the last 12 months; the older call history is available to Premium members. Implied return is the move implied if the consensus target were hit. These are forward-looking predictions, not realized returns. Per-analyst ratings and track records are a Premium feature.
NRSN elsewhere on AnalystEdge
The most recent congressional, executive-branch and insider filings matched to this ticker. Matched by ticker symbol — occasional mismatches are possible. Not investment advice.
Trending today: not in any of today's trending tables (Gaining attention, Losing attention, Most followed)
| Date | Source | Who | Action | Detail | Amount |
|---|---|---|---|---|---|
| 2025-08-01 | Executive | Zeldin, LeeAdministrator | Purchase | NeuroSense Therapeutics Ltd. Ordinary Shares (NRSN) | $1,001 - $15,000 |
| 2025-08-01 | Executive | Zeldin, LeeAdministrator | Purchase | NeuroSense Therapeutics Ltd. Ordinary Shares (NRSN) | $1,001 - $15,000 |
| 2025-05-13 | Executive | Zeldin, LeeAdministrator | Sale | NeuroSense Therapeutics Ltd. Ordinary Shares (NRSN) | $1,001 - $15,000 |
| 2025-05-13 | Executive | Zeldin, LeeAdministrator | Sale | NeuroSense Therapeutics Ltd. Ordinary Shares (NRSN) | $1,001 - $15,000 |
More: insider activity · executive branch · trending